Literature DB >> 21400240

Accumulation and distribution of doxorubicin in tumour spheroids: the influence of acidity and expression of P-glycoprotein.

Howard R Mellor1, Richard Callaghan.   

Abstract

PURPOSE: The intra-tumour distribution of anticancer drugs remains an important, but often under-estimated, influence on drug efficacy. Tumour acidity and the presence of efflux pumps were examined for their influence on the distribution of doxorubicin in a solid tumour model.
METHODS: Anticancer drug distribution and overall accumulation was measured in tumour spheroids (TS) of varying sizes. The distribution profiles were examined in normoxic and hypoxic TS, the latter generating metabolic acidosis. Finally, the drug distribution profiles were related to efficacy using radial outgrowth assays.
RESULTS: In large tumour spheroids (TS) (d ~500 μm), intracellular accumulation of doxorubicin was restricted to cells in the outermost layers and failed to accumulate within the viable cells in the 'intermediate' hypoxic zone. A similar profile was obtained for another protonatable amine, 7-AAD. In contrast, the distribution of the non-ionisable drug (at physiological pH) BODIPY-Taxol was uniform throughout the TS. In order to independently model the hypoxic and normoxic zones of TS, we compared drug accumulation in small entirely normoxic TS (d ~200 μm) with equivalent sized ones exposed to hypoxia in an anaerobic chamber. Exposure of TS to hypoxia caused a considerable reduction in the pH of the bathing medium and lower tissue accumulation of doxorubicin. Interstitial acidity reduces the proportion of doxorubicin in the non-ionised form.
CONCLUSIONS: In TS, the accumulation and distribution of doxorubicin was influenced by both the expression of P-glycoprotein and hypoxia-induced acidity. Therefore, optimisation of doxorubicin chemotherapy for hypoxic tumours will require circumvention of both of these crucial pharmacokinetic determinants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400240     DOI: 10.1007/s00280-011-1598-8

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

1.  Effects of extracellular acidity on resistance to chemotherapy treatment: a systematic review.

Authors:  Viviane Palmeira da Silva; Carulina Bueno Mesquita; Júlia Silveira Nunes; Bianca de Bem Prunes; Pantelis Varvaki Rados; Fernanda Visioli
Journal:  Med Oncol       Date:  2018-10-30       Impact factor: 3.064

2.  Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.

Authors:  Federico Perche; Niravkumar R Patel; Vladimir P Torchilin
Journal:  J Control Release       Date:  2012-09-10       Impact factor: 9.776

3.  Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.

Authors:  Z Qin; L Dai; M Bratoeva; M G Slomiany; B P Toole; C Parsons
Journal:  Leukemia       Date:  2011-06-10       Impact factor: 11.528

4.  Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules.

Authors:  Anjani Kumar; Sukh Mahendra Singh
Journal:  Mol Cell Biochem       Date:  2012-08-15       Impact factor: 3.396

5.  Cancer cell spheroids as a model to evaluate chemotherapy protocols.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

6.  In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog.

Authors:  Charng Choon Wong; Nagarajan Periasamy; Sreenivasa Rao Sagineedu; Shiran Sidik; Shariful Hasan Sumon; Paul Loadman; Roger Phillips; Nordin Haji Lajis; Johnson Stanslas
Journal:  Invest New Drugs       Date:  2014-05-31       Impact factor: 3.850

7.  Hypoxia as a target for drug combination therapy of liver cancer.

Authors:  Cressida Bowyer; Andrew L Lewis; Andrew W Lloyd; Gary J Phillips; Wendy M Macfarlane
Journal:  Anticancer Drugs       Date:  2017-08       Impact factor: 2.248

8.  Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles.

Authors:  Austin R Holub; Anderson Huo; Kavil Patel; Vishal Thakore; Pranav Chhibber; Folarin Erogbogbo
Journal:  Int J Mol Sci       Date:  2020-06-21       Impact factor: 5.923

9.  Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression.

Authors:  Evgeny V Denisov; Nikolay V Litviakov; Marina V Zavyalova; Vladimir M Perelmuter; Sergey V Vtorushin; Matvey M Tsyganov; Tatiana S Gerashchenko; Evgeny Yu Garbukov; Elena M Slonimskaya; Nadezhda V Cherdyntseva
Journal:  Sci Rep       Date:  2014-04-16       Impact factor: 4.379

10.  Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.

Authors:  Blenda Chi Kwan Wong; Hongqi Zhang; Ling Qin; Hubiao Chen; Chen Fang; Aiping Lu; Zhijun Yang
Journal:  Drug Des Devel Ther       Date:  2014-07-22       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.